Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |